Evoke Pharma Inc. sell StockNews.com
Start price
27.02.23
/
50%
€2.64
Target price
27.02.24
-
Performance (%)
-78.41%
End price
28.02.24
€0.57
Summary
This prediction ended on 28.02.24 with a price of €0.57. StockNews_com correctly predicted massive losses of -78.41% for Evoke Pharma Inc.. StockNews_com has a follow-up prediction for Evoke Pharma Inc. where he still thinks Evoke Pharma Inc. is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evoke Pharma Inc. | - | - | - | - |
| iShares Core DAX® | -1,10 % | -6,08 % | 0,87 % | 54,49 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 18,26 % | 85,55 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 26,34 % | 55,41 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 13,29 % | 62,99 % |
Comments by StockNews_com for this prediction
In the thread Evoke Pharma Inc. diskutieren
Evoke Pharma, Inc. (NASDAQ: EVOK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for EVOK provided by MarketBeat
In the thread Trading Evoke Pharma Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten